CITADEL ADVISORS LLC quarter change: USA Other Stocks, Unchanged
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), from the quarter ended 2025-12-31 to 2026-03-31, CITADEL ADVISORS LLC opened 163 positions, added to 93, reduced 91, sold out of 310 and left 5 unchanged. The largest increase in value was INFLEQTION INC (+$23,471,651); the largest decrease was INDIVIOR PLC (-$109,861,044).
- SPRUCE BIOSCIENCES INC: Country of operation United States; Class COM NEW; Shares 2025-12-31 69,999; Shares 2026-03-31 69,999.
- NUSATRIP INC: Country of operation —; Class COM; Shares 2025-12-31 149,270; Shares 2026-03-31 149,270.
- QUANTUM BIOPHARMA LTD: Country of operation —; Class CL B SUB VTG SHS; Shares 2025-12-31 15,863; Shares 2026-03-31 15,863.
- OSTIN TECHNOLOGY GROUP CO LT: Country of operation —; Class SHS NEW CL A; Shares 2025-12-31 34,652; Shares 2026-03-31 34,652.
Two Form 13F-HR filings compared (SEC CIK 1423053): 2025-12-31 (filed 2026-02-17) and 2026-03-31 (filed 2026-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.